Categories
Uncategorized

Systemic Therapy for Advanced Metastatic Thyroid Cancer with Dr. Busaidy: How I Do It?

Dr. Naifa Busaidy joins host Dr. Dana Hartl to discuss the clinical decisions involved in systemic therapy for advanced metastatic thyroid cancer. They explore how disease progression, symptoms, tumor location and potential risks can inform when treatment may be considered, while recognizing that the decision is not the same for every patient.

Dr. Busaidy describes how molecular testing can help inform treatment selection and why multidisciplinary communication matters, especially when local treatment options or potential complications are part of the discussion. She also shares how she approaches monitoring and side effect conversations, including ways clinicians can help patients understand what to watch for and when to reach out.

The conversation turns to quality of life, patient goals and the challenges of discussing long-term treatment and prognosis. Dr. Busaidy reflects on the need for more research, clinical trials and better tools for goals-of-care conversations, while emphasizing that clinicians should engage patients and take their individual circumstances into account.